UpLift, a behavioral health company, has significantly expanded its reach in the United States by acquiring Minded, an online psychiatry service specializing in women’s care. This strategic move allows UpLift to offer team-based therapy and psychiatry services across all 50 states, starting with California, Illinois, New York, Pennsylvania, and Texas. Previously, UpLift’s operations were limited to a handful of states, including Florida,…
Meeno, a relationship mentoring startup, has successfully raised a $3.9M seed round led by Sequoia Capital, with participation from Andrew Ng’s AI Fund and NEA. The company, formerly known as Amorai, had previously raised funds during its pre-seed round in April (read more here), which brings its total funding to nearly $5M. Meeno, pronounced ‘me-know,’ is an AI-powered relationship mentoring app that…
Equip, a frontrunner in the field of virtual eating disorder treatment, has announced its expansion to include adult patients in the United States. With this move, the company aims to provide comprehensive care and address significant gaps in the traditional treatment landscape. Equip, founded in 2019, has been at the forefront of offering evidence-based treatment to adolescents and young adults struggling with…
Woman-led mental health platform EverBlume recently made its debut, positioning itself as an essential sobriety resource for individuals grappling with alcohol-related issues. At a time when substance abuse is rampant — with roughly 40 million Americans aged 12 and up needing treatment for substance abuse disorders in 2020 — resources have become increasingly scarce. EverBlume is stepping up to remedy this gap…
The U.S. Food and Drug Administration (FDA) has approved Zurzuvae (zuranolone), the first oral medication indicated to treat postpartum depression (PPD) in adults. PPD is a major depressive episode that typically occurs after childbirth but can also begin during the later stages of pregnancy. Until now, treatment for PPD was only available as an IV injection given by a healthcare provider in certain healthcare…
The SKYLARK Study, conducted by The Feinstein Institutes for Medical Research at Northwell Health, has shown promising results in treating postpartum depression (PPD). Led by Dr. Kristina M. Deligiannidis, the trial evaluated the efficacy of an investigational oral neuroactive steroid, zuranolone (50mg). The findings suggest zuranolone could become the first oral, at-home therapy approved by the FDA for PPD. The study included…
San Francisco-based digital therapeutics leader, Big Health, is taking on the growing youth mental health crisis by acquiring Limbix, a company specializing in evidence-based digital therapeutics for adolescents and young adults with depression symptoms. The move expands Big Health’s therapeutic portfolio, which previously focused on insomnia and anxiety treatments for adults. The COVID-19 pandemic has exacerbated the mental health crisis among young…
EXHALE, an emotional well-being app for Black Women and Women of Color, has released a new report highlighting the insufficient number of self-care resources specifically created for Black Women. “The State of Self-Care for Black Women” report offers insights into the stress, racial trauma, and enduring the stereotype of strength that impacts Black Women’s mental, emotional, and physical health. Surveying 1,005 Black…
